Deepak Nitrite Limited has informed the Exchange about Transcript
DEEPAKNTR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deepak Nitrite shared the transcript of its Q4 & FY25 earnings call held on May 29, 2025. For FY25, the company reported total income of INR 8,366 crore (up 8% YoY), EBITDA of INR 1,176 crore (margin 14%, nearly flat vs FY24), PBT of INR 9,53 crore, and PAT of INR 697 crore. Q4 FY25 showed strong recovery with revenue of INR 2,202 crore (up 14% QoQ), EBITDA of INR 339 crore (up 79% QoQ), and PAT of INR 202 crore (up 106% QoQ), partly aided by government incentives of INR 161 crore (normal annual accrual is INR 60-70 crore). The Advanced Intermediates segment grew 19% QoQ in Q4 but was down 7% for the full year, while the Phenolics segment grew 16% YoY to INR 5,805 crore in FY25. Management guided that the worst of the pricing pressure is behind and expects normalized, higher profitability in FY26. A strong project pipeline includes a nitric acid plant (Q1-Q2 FY26), R&D center in Vadodara (Q2 FY26), MIBK/MIBC project (H2 FY26), and a major INR 8,500 crore polycarbonate integrated complex. The Board maintained a dividend of INR 7.5 per share.
The transcript confirms a bottoming-out in Q4 FY25 with sharp sequential recovery in earnings and provides forward visibility on major capex-led growth projects. Shareholders can expect improving margins in FY26, supported by new capacity commissioning, though near-term pricing remains uncertain due to Chinese imports and geopolitical risks. The maintained dividend signals continued shareholder rewards.